Compare American Well Corp (AMWL) vs Direxion Daily FTSE China Bull 3x Shares (YINN) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
American Well Corp vs Direxion Daily FTSE China Bull 3x Shares — how do they compare? American Well Corp trades at $9.61 (market cap $165.58M), while Direxion Daily FTSE China Bull 3x Shares trades at $25.43. The key difference: American Well Corp is trading nearer its 52-week high, Direxion Daily FTSE China Bull 3x Shares nearer its low. Which is the better fit depends on your goals.
| AMWL | YINN | |
|---|---|---|
Market Cap | $165.58M | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $9.91 | $56.62 |
52-Week Low | $3.78 | $21.45 |
Enterprise Value | -$9.66M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMWL trades at $9.91, up 8.66% today, with bullish technical signals and positive momentum. The company shows improving financial trends with declining losses and strong gross margins of 52.9%, though it remains unprofitable with a -37.02% net margin. Recent news highlights Amazon's appointment of Amwell's co-founder to lead its healthcare unit, signaling industry validation.
While AMWL shows operational improvement and attractive valuation multiples (P/S 0.68, P/B 0.73), the stock faces headwinds from persistent losses and negative cash flow. Analyst consensus is cautious with a $7.25 price target below current levels, suggesting limited near-term upside despite recent positive momentum.
YINN trades at $25.36, up 0.6% with a bullish technical signal despite mixed indicators. The ETF shows neutral oscillators but bearish moving averages, with key resistance at $26. Recent news highlights China's AI investment push and improved macro sentiment, though geopolitical tensions with the U.S. persist. The fund's leveraged structure amplifies both gains and risks in Chinese equities.
Outlook remains cautious due to YINN's 3x leverage amplifying volatility. Opportunities exist from China's $295 billion AI infrastructure plan and strong export growth, but risks include U.S.-China tech rivalry, regulatory scrutiny, and value trap concerns. Investors should weigh leveraged exposure against fundamental headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About American Well Corp
American Well Corp is a telehealth company enabling digital delivery of care for its customers. Its platform, Amwell, digital care delivery solution that equips health systems, health plans, government, and innovator clients with the tools to enable new models of care for their patients and members enabling care delivery across the full healthcare continuum - from primary and urgent care in the home to high acuity specialty consults, such as telestroke and telepsychiatry, in the hospital. It provides both on-demand and scheduled consultations. Its Health Plan Programs include Virtual Primary Care, Musculoskeletal Care, Dermatology Care, and Chronic Care among others and its Health System Modules include Acute Behavioral Health, ED Triage, Pediatrics and Telestroke among others.
Read more on AMWL →About Direxion Daily FTSE China Bull 3x Shares
YINN is a leveraged ETF that seeks daily investment results, before fees and expenses, of 300% (3x) of the daily performance of the FTSE China 50 Index. It is a tactical instrument designed for sophisticated traders seeking to magnify short-term bullish views on large-cap Chinese equities, primarily those trading on the Hong Kong Stock Exchange.
Read more on YINN →
